Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia	Sanofi	Ongoing	2-combination hypoglycaemics	4	DIREG_L_05386	Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after DOCETAXEL-based regimen	Sanofi	Ongoing	N/A	4	DRIEG_C_05756	King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
An observational Study to evaluate the behaviour of physicians focusing on the preference patterns (reasons to prescribe) of ARB/HCTZ combinations containing high dose (25mg) diuretic for treatment of hypertension in Saudi Arabia	Sanofi	Ongoing	N/A	4	IRBEH_L_05674	King Khalid University Hospital (Riyadh)
Effect of ACS Patients' Education on Adherence to Dual Anti-platelet Therapy (unstable angina + non ST elevation MI + ST elevation MI)	Sanofi	Ongoing	N/A	4	DIREG_L_05229	Dr. Soliman Fakeeh Hospital (Jeddah)
Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen.	Sanofi	Ongoing	Lantus® + Apidra®	4	LANTU_R_05033	King Khalid University Hospital (Riyadh)
Study of clinical and non clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice	Sanofi	Ongoing	Lantus®/Apidra®	4	LANTUR06314	Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry on the use of Lactic acid (Lactacyd) in minor gynecologyical conditions among Middle Eastren women	Sanofi	Ongoing	LACTOSERUM LACTIC ACID	4	LACACL06308	Dr. Erfan & Bagedo General Hospital (Jeddah)
multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 & 5D	Sanofi	Ongoing	N/A	4	OBS13593	Saudi center for organ transplantation (Riyadh), King Fahad Hospital (Jeddah)
Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab Progression: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)	GSK	Ongoing	Lapatinib / Capecitabine	4	113780	King Abdulaziz Medical City NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah)
An Observational, Cross-sectional Study on the Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in adult Population within the MENA Region.	GSK	Ongoing	N/A	4	Version 2.1 - 30/08/2009	Prince Sultan Military Medical City (Riyadh)